Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Share your knowledge and expertise with your regulatory peers by submitting an in-depth, evidence-based article focusing on key areas and emerging issues in the global regulatory landscape.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
RAPS Euro Convergence brings regulatory peers from the EU and worldwide together in one forum to gain insights and exchange ideas on the region's most pressing issues. Register today to attend 10-12 May 2021.
Registration is now open for RAPS Convergence 2021! Gather with the regulatory community 12-15 September for four days of learning, engagement, and excitement.
With contributions from more than 30 authors from seven countries, the new edition incorporates a global overview of the field and is designed to help you get the most out of your regulatory intelligence endeavors.
Regipedia is an interactive resource created to benefit RAPS members with 24/7 access to more than 2,300 regulatory terms.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window. We apologize for any inconvenience caused during this time.
Posted 04 January 2012 | By Alexander Gaffney, RAC
Last year was a banner year for drug shortages, according to information just released by the University of Utah Drug Information Service.
267 medications experienced shortages during 2011, topping the previous year's record of 211, and exceeding 2004 levels by 460%.
The issue has attracted the attention of both the US Food and Drug Administration (FDA) and President Barack Obama. The FDA has launched a drug shortages program to work with manufacturers and providers to ease problems and bring products back to market faster, and has advocated for enhanced authority to mandate drug shortage reporting. President Obama released an Executive Order on 31 October that orders the FDA to create an early-warning system.
Neither effort seems to have done much to solve the problem. Erin Fox, manager of the University of Utah's Drug Information Service, says that the current shortages are likely to continue based on current trends.
The shortages have primarily been the result of manufacturing issues, such as quality and sterility issues, and low profit margins for drugs with only a single source as the result of consolidation in the generic pharmaceutical industry. Medicare price controls, too, have been implicated in the shortages.
More FAQ's, including contact information for the FDA's Drug Shortage Program (DSP), can be found on the FDA's website.
Tags: Record, Executive order, Drug Shortage, Latest News, Obama, 2011
Regulatory Focus newsletters
All the biggest regulatory news and happenings.